Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Bristol-Myers Seeks Academic Access

by Michael McCoy
August 11, 2014 | A version of this story appeared in Volume 92, Issue 32

Bristol-Myers Squibb has formed an alliance with Boston-based Allied Minds aimed at tapping research and preclinical drug development from U.S. universities. Eight-year-old Allied Minds works with 33 U.S. universities to form companies based on academia-invented technology. Under the agreement, BMS and Allied Minds have created Allied-Bristol Life Sciences to work with university researchers on forming drug discovery companies. BMS will have the option to acquire successful firms from Allied-Bristol.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.